• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎自评工具的验证。

Validation of a Hidradenitis Suppurativa Self-Assessment Tool.

机构信息

1 Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

2 Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

出版信息

J Cutan Med Surg. 2019 Jul/Aug;23(4):388-390. doi: 10.1177/1203475419839965. Epub 2019 Mar 22.

DOI:10.1177/1203475419839965
PMID:30897946
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is a debilitating dermatologic condition presenting with recurrent abscesses. While there are multiple scales to determine HS severity, none are designed for self-administration. A validated severity self-assessment tool may facilitate survey research and improve communication by allowing patients to objectively report their HS severity between clinic visits.

OBJECTIVES

The purpose of this study was to assess a self-administered HS measure.

METHODS

An HS self-assessment tool (HSSA) with 10 photographs of different Hurley stages was developed. The tool was administered to patients diagnosed with HS who visited the Wake Forest Baptist Health dermatology clinic over a span of 2 months. Physician-administered Hurley stage was recorded to determine criterion validity. To assess test-retest reliability of the measure, patients completed the HSSA again at least 30 minutes after the first completion.

RESULTS

Twenty-four patients completed the measure, and 20 of these patients completed it twice. Agreement between physician-determined Hurley stage and self-determined Hurley stage was 66.7% with a weighted kappa of 0.57 (95% confidence interval [CI]: 0.30-0.84). The weighted kappa for agreement between patients' initial and second completion of the HSSA was 0.81 (95% CI: 0.64-0.99).

CONCLUSIONS

The self-administered measure provides moderate agreement with physician-determined Hurley stage and good test-retest reliability.

摘要

背景

化脓性汗腺炎(HS)是一种使人衰弱的皮肤病,表现为反复脓肿。虽然有多种量表来确定 HS 的严重程度,但没有一种是专为自我管理设计的。经过验证的严重程度自我评估工具可以通过允许患者在就诊之间客观地报告其 HS 严重程度来促进调查研究并改善沟通。

目的

本研究旨在评估一种自我管理的 HS 措施。

方法

开发了一种带有 10 张不同 Hurley 阶段照片的 HS 自我评估工具(HSSA)。该工具在 2 个月的时间内对在维克森林浸信会健康皮肤科诊所就诊的诊断为 HS 的患者进行了管理。记录了医生管理的 Hurley 阶段以确定标准效度。为了评估该措施的重测信度,患者在第一次完成后至少 30 分钟后再次完成 HSSA。

结果

24 名患者完成了该措施,其中 20 名患者完成了两次。医生确定的 Hurley 阶段与自我确定的 Hurley 阶段之间的一致性为 66.7%,加权 kappa 值为 0.57(95%置信区间[CI]:0.30-0.84)。患者首次和第二次完成 HSSA 之间的加权 kappa 值为 0.81(95% CI:0.64-0.99)。

结论

自我管理的措施与医生确定的 Hurley 阶段具有中度一致性,并且具有良好的重测信度。

相似文献

1
Validation of a Hidradenitis Suppurativa Self-Assessment Tool.化脓性汗腺炎自评工具的验证。
J Cutan Med Surg. 2019 Jul/Aug;23(4):388-390. doi: 10.1177/1203475419839965. Epub 2019 Mar 22.
2
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
3
Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.居民能否充分评估化脓性汗腺炎的严重程度?主要评分系统的组内和组间可靠性评估。
Dermatology. 2020;236(1):8-14. doi: 10.1159/000501771. Epub 2019 Sep 5.
4
Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa.化脓性汗腺炎 Hurley 分期的组内和组间可靠性。
Br J Dermatol. 2019 Aug;181(2):344-349. doi: 10.1111/bjd.17588. Epub 2019 Mar 14.
5
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.化脓性汗腺炎结局评估工具和分期系统的评价者间信度和可靠性。
Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.
6
A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.一种用于化脓性汗腺炎的新型严重程度评估评分系统。
JAMA Dermatol. 2018 Mar 1;154(3):330-335. doi: 10.1001/jamadermatol.2017.5890.
7
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.国际化脓性汗腺炎严重程度评分系统(IHS4)的制定与验证,一种新型动态评分系统,用于评估 HS 严重程度。
Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.
8
Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.化脓性汗腺炎临床反应在化脓性汗腺炎患者评估中的可靠性
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2254-2256. doi: 10.1111/jdv.15163. Epub 2018 Jul 17.
9
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.HIDRAdisk:评估化脓性汗腺炎负担的创新视觉工具的验证。
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773. doi: 10.1111/jdv.15425. Epub 2019 Mar 5.
10
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.化脓性汗腺炎改良 Hurley 分级与患者报告的生活质量和客观疾病严重程度评估的相关性。
Br J Dermatol. 2019 May;180(5):1214-1220. doi: 10.1111/bjd.17508. Epub 2019 Feb 25.

引用本文的文献

1
Stigmatization, a social perception which may have a debilitating impact on hidradenitis suppurativa patients: an observational study.污名化,一种可能对化脓性汗腺炎患者产生不良影响的社会认知:一项观察性研究。
Arch Dermatol Res. 2023 May;315(4):1049-1052. doi: 10.1007/s00403-022-02412-5. Epub 2022 Oct 31.
2
Hidradenitis Suppurativa's Impact on Social Activities: An Observational Study.化脓性汗腺炎对社交活动的影响:一项观察性研究。
Cureus. 2022 May 24;14(5):e25292. doi: 10.7759/cureus.25292. eCollection 2022 May.
3
Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
自我报告的化脓性汗腺炎严重程度:对临床实践有用吗?
Dermatol Ther (Heidelb). 2022 Apr;12(4):899-909. doi: 10.1007/s13555-022-00701-5. Epub 2022 Mar 10.
4
Emotional Well-Being Is Impaired in Hidradenitis Suppurativa Patients.化脓性汗腺炎患者的情绪健康受损。
Skin Appendage Disord. 2019 Nov;5(6):366-369. doi: 10.1159/000502296. Epub 2019 Sep 10.